Cornerstone Planning Group’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-155
Closed -$14.6K – 925
2026
Q2
$14.6K Buy
155
+1
+0.6% +$91 ﹤0.01% 775
2026
Q1
$13.1K Buy
154
+1
+0.7% +$100 ﹤0.01% 820
2025
Q4
$15K Buy
153
+15
+11% +$1.29K ﹤0.01% 673
2025
Q3
$10.5K Buy
+138
New +$9.2K ﹤0.01% 766
2025
Q2
– Sell
-62
Closed -$3.27K – 1611
2025
Q1
$3.27K Buy
+62
New +$3.48K ﹤0.01% 847
2024
Q3
– Sell
-15
Closed -$664 – 1329
2024
Q2
$664 Buy
+15
New +$638 ﹤0.01% 1034

Other funds holding IRMD

Cornerstone Planning Group's IRMD Position: Q3 2026 in Review

Cornerstone Planning Group sold out of iRadimed (IRMD) in Q3 2026, closing a stake of 155 shares — an estimated $14.6K sold.

Cornerstone Planning Group first reported a position in IRMD in Q2 2024 and held it in 6 quarters. The position peaked at $15K in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Cornerstone Planning Group reported no remaining iRadimed position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 155 iRadimed shares in Q3 2026, an estimated $14.6K.
  • Cornerstone Planning Group first reported a position in iRadimed in Q2 2024 and held it in 6 quarters.
  • Cornerstone Planning Group's iRadimed position peaked at $15K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.